Tune in to the episode wherever you listen to podcasts.
Apple Podcasts - https://t.co/8uEOnNA3Qu
Spotify - https://t.co/v4pHbQ7si7
YouTube - https://t.co/Nl9upvief6
Weill Cornell Medicine website – https://t.co/8MkdwF4W6L
Can AI actually foster more empathy in doctor-patient communication?
Join me, @kimberly_kuk and @dougfloramd for a panel discussion on how AI is transforming the doctor-patient dialogue in cancer care!
Scan the QR to register.
Take a BITE out of cancer! Dr @mmejia91 recently came on the @WeillCornell#CancerCast podcast to discuss how bispecific t-cell engager, or BiTE, therapy works to target #cancer, common side effects & how this treatment differs from other #immunotherapy https://t.co/YrKcActc8R
Checkout #CancerCast - a cancer oriented Podcast on new therapies in cancer! #Oncology@OncoAlert
I spoke with #Melanoma expert Dr. Barbara Ma about the “nuts & bolts” of this new form of cellular immunotherapy & what the future holds for other cancers https://t.co/2AA4FhVEp1
Happening next at #ESMO25: @YJanjigianMD will lead a session on how she and other experts are identifying new treatments to improve outcomes for those with gastroesophageal adenocarcinoma. @MSKCancerCenter@myESMO
Learn more: https://t.co/uAmKdFHSbV
GPC3 directed Radioligand Therapy in HCC: Honored to present Trials in Progress Poster @ESMO_Open@ONealCancerUAB. Great to run into good friend and collaborator, @HardingJJMD#esmo2025
Enrollment is ongoing!!
🙏@ChiaraCrem1@esmo#ESMO25 for reminding providers that IO therapy in #TMBhigh in MSS #colorectal#cancer provides NO benefit despite agnostic FDA approval. Yamaguchi et al, ESMO open, 2025. I have been reiterating this repeatedly, so IMP to use regular chemo in this setting. #CancerResearch @myESMO
From OGs 🧬 to next-gen therapies 🚀 Honored to sit down with the pioneers who shaped HER2 as a target. Our new CME activity with @touchONCOLOGY is now live:
👉 https://t.co/cqiM02v7Tk @MSKCancerCenter
Hi ALL
Did one new experiment on oncology social media 🙂
Made my account on Substack and uploaded my article on it 👇
If you find it useful, DO share or subscribe and comment 🙂.
https://t.co/vdGEf10Vb6
Read more from our co-chairs on the importance of protecting public support for biomedical research: https://t.co/iZjvYy1cKX #CancerResearch#ClinicalTrials
That feeling when 7+ years of work lands on the front page of @NEJM—and one of the people I respect most, @KoheiShitara , writes the editorial. Honored to share this moment with you, Kohei. Here’s to a decade of friendship, and curing gastric cancer. #Matterhorn@MSKCancerCenter
🗞️📄Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group | JCO Precision Oncology https://t.co/W0KtMU9Fxs
@aparna1024@FlavioRochaMD@SyedAAhmad5@NMSurgery
🧬ctDNA in clinical trials of GI cancers:
Position paper of NCI GI Onc WG
@JCOPO_ASCO
➡️Prospective trials are required
➡️Group supports
✅ctDNA as a primary efficacy end point for phase II studies
✅as a noninvasive evaluation strategy for new drug development
👉https://t.co/HP9u207eWL
@ASCO@JCOOP_ASCO@JCOGO_ASCO@OncoAlert@realbowtiedoc #cancer #oncology #MedX